Though some studies show slight improvement of apathy with cholinesterase inhibitors, the aforementioned meta-analysis did not find high-quality evidence to support the use of any cholinesterase inhibitor (donepezil, galantamine or rivastigmine) for apathy in Alzheimer’s [31]. This evidence concerns the gene BCHE and Apathy.